Skip to main content
. Author manuscript; available in PMC: 2017 Sep 18.
Published in final edited form as: Gynecol Oncol. 2017 Jul 11;146(3):588–595. doi: 10.1016/j.ygyno.2017.07.003

Figure 2.

Figure 2

A) Tumor volume by MMR class for all histologies and for endometrioid histology only. B) Tumor volume and lymph node status for all endometrioid cases with lymphadenectomy performed and by epigenetic MMR defective and MMR proficient tumors.